Our top pick for
Delek US Holdings Inc is an oil & gas refining & marketing business based in the US. Delek US shares (DK) are listed on the NYSE and all prices are listed in US Dollars. Delek US employs 3,532 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$21.25|
|52-week range||$8.92 - $27.38|
|50-day moving average||$18.35|
|200-day moving average||$19.76|
|Wall St. target price||$23.27|
|Dividend yield||$0.31 (1.45%)|
|Earnings per share (TTM)||$-7.60|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||6.25%|
|1 month (2021-09-20)||33.40%|
|3 months (2021-07-23)||28.63%|
|6 months (2021-04-23)||-0.75%|
|1 year (2020-10-23)||94.78%|
|2 years (2019-10-24)||-44.27%|
|3 years (2018-10-24)||35.67|
|5 years (2016-10-24)||21.78%|
Valuing Delek US stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Delek US's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Delek US's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $22.2 million.
The EBITDA is a measure of a Delek US's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$8.5 billion|
|Gross profit TTM||$-1,400,000|
|Return on assets TTM||-3.84%|
|Return on equity TTM||-41.86%|
|Market capitalisation||$1.6 billion|
TTM: trailing 12 months
There are currently 3.8 million Delek US shares held short by investors – that's known as Delek US's "short interest". This figure is 25.3% up from 3.0 million last month.
There are a few different ways that this level of interest in shorting Delek US shares can be evaluated.
Delek US's "short interest ratio" (SIR) is the quantity of Delek US shares currently shorted divided by the average quantity of Delek US shares traded daily (recently around 879348.02784223). Delek US's SIR currently stands at 4.31. In other words for every 100,000 Delek US shares traded daily on the market, roughly 4310 shares are currently held short.
However Delek US's short interest can also be evaluated against the total number of Delek US shares, or, against the total number of tradable Delek US shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Delek US's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Delek US shares in existence, roughly 50 shares are currently held short) or 0.061% of the tradable shares (for every 100,000 tradable Delek US shares, roughly 61 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Delek US.
Find out more about how you can short Delek US stock.
We're not expecting Delek US to pay a dividend over the next 12 months.
Over the last 12 months, Delek US's shares have ranged in value from as little as $8.92 up to $27.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Delek US's is 2.0571. This would suggest that Delek US's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Delek US Holdings, Inc. engages in the integrated downstream energy business in the United States. The company operates in three segments: Refining, Logistics, and Retail. The Refining segment processes crude oil and other purchased feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal. It owns and operates four independent refineries located in Tyler, Texas; El Dorado, Arkansas; Big Spring, Texas; and Krotz Springs, Louisiana, as well as three biodiesel facilities in Crossett, Arkansas, Cleburne, Texas, and New Albany. The Logistics segment gathers, transports, and stores crude oil, intermediate, and refined products; and markets, distributes, transports, and stores refined products for third parties. It owns or leases capacity on approximately 400 miles of crude oil transportation pipe, and lines, approximately 450 miles of refined product pipelines, an approximately 900-mile crude oil gathering system, and associated crude oil storage tanks with an aggregate of approximately 10.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.